سعر ترستنال Trustnal‏ 100مجم/5مل معلق 100 مل 2026

• Most common in controlled trials (2% or more): abdominal pain, headache, chromaturia (discoloured urine) and nausea. Postmarketing (tablets): diarrhea, gastroesophageal reflux disease, dizziness, dyspnea, rash and urticaria.International label, same formulation · DailyMed (US National Library of Medicine)

• Prior hypersensitivity to nitazoxanide or any other ingredient of the formulation.International label, same formulation · DailyMed (US National Library of Medicine)

• Limitation of use: not shown to be effective for diarrhea caused by Cryptosporidium parvum in HIV-infected or immunodeficient patients (not superior to placebo); not studied for Giardia in these patients.International label, same formulation · DailyMed (US National Library of Medicine)

• Highly protein-bound drugs with a narrow therapeutic index (e.g. warfarin)Tizoxanide (active metabolite) is over 99.9% plasma-protein bound; competition for binding sites may occur, so monitor for adverse reactions.DailyMed (US National Library of Medicine)

• No data in pregnant women to inform a drug-associated risk; no teratogenicity or fetotoxicity in rats and rabbits at 30 and 2 times the human exposure at the maximum recommended dose.International label, same formulation · DailyMed (US National Library of Medicine)
• No information on presence in human milk, effects on the breastfed infant or milk production; weigh breastfeeding benefits against the mother's need for the drug.International label, same formulation · DailyMed (US National Library of Medicine)

English text not available for this section.